Swiss healthcare behemoth Roche Holding AG., recent unveiled that its Tecentriq immunotherapy merged with chemotherapy secured the top Priority Review approval from the U.S. watchdog. Reportedly, the Tecentriq will be used for treating a type of lung cancer – SCLC (extensive-stage small cell lung cancer). …
Medtronic Plc, the U.S. based medical device company recently agreed to pay a fine of $50.9 million for the questionable means adopted by Medtronic acquired companies to market medical devices as well as devices meant for the treatment of vascular defect in the brain. Federal …
Norway’s pharmaceutical major Ultimovacs recently announced that in its IPO (Initial Public Offering) in early 2019, it has plans to raise about 700 million Norwegian crowns (USD 82 million). Reportedly, the company aims to develop its immunotherapy cancer drug with the help of the raised …
argenx SE, a Netherland-based biotechnology firm that develops a large range of differentiated antibody-based therapies for treating severe autoimmune diseases and cancer, has recently inked a deal with Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson (J&J), to develop …
Reports confirm that Mumbai based Sun Pharmaceutical Industries Ltd. has recently received final approval from the U.S. Food and Drug Administration (FDA) for the company’s abbreviated new drug application (ANDA) for the generic version of Ganirelix Acetate Injection, 250 mcg/0.5 mL. Apparently, this generic version …
Digital medication management firm MedAdvisor Limited has announced the signing of a Heads of Agreement to form a joint venture with one of Asia’s largest healthcare services groups, Zuellig Pharma Holdings Pvt. Ltd. Under the agreement, MedAdvisor and Zuellig Pharma would form a Singapore based …
Canadian smartphone maker BlackBerry Limited has reportedly declared that it has become a HIMSS Analytics Certified Consultant to assist in addressing the digital infrastructure requirements of healthcare establishments across the globe. As per trusted sources, BlackBerry would now help healthcare institutions through the stages of …
German drug manufacturer Bayer AG, which recently acquired the U.S. agrochemical company Monsanto, has announced that it is selling a number of its businesses, cutting down around 12,000 jobs and taking $3.8 billion in impairments. Apparently, Bayer would cut down about 12,000 of its 118,200 …
Aimmune Therapeutics Inc., a California-based clinical-stage biopharmaceutical company, has reportedly announced that it has closed the $98 million equity investment by Nestlé Health Science. Reports cite, Nestlé Health Science bought about 3,237,529 newly issued shares of the Brisbane, California-headquartered Aimmune Therapeutics’ common stock, at a …
